Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2009
12/17/2009US20090311264 Use of Disorazoles and Their Derivatives for the Treatment of Benign and Malignant Oncoses
12/17/2009US20090309076 Photochromic compounds
12/17/2009CA2727373A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
12/17/2009CA2727032A1 Novel tricyclic compounds
12/16/2009EP2132191A2 Method for manufacturing neuraminic acid derivatives
12/16/2009EP1904057B1 Hydroquinone ansamycins in the treatment of gastrointestinal stromal tumors
12/16/2009EP1451194B2 Preparation of levofloxacin hemihydrate
12/16/2009CN100569944C Production of polyketides and other natural products
12/15/2009US7632839 Kinesin spindle protein (KSP) inhibitors, e.g., N-(3-amino-2-(R,S)-fluoropropyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-2-yl)-2-(R,S)-methylpropyl]-4-methylbenzamide; antiproliferative and -carcinogenic agents; side effects reduction
12/15/2009US7632833 Mitotic kinesin inhibitors
12/15/2009US7632830 Lactam compounds and pharmaceutical use thereof
12/15/2009CA2345295C Use of fused pyrrolocarbazoles in preventing/treating damage to sensory hair cells and cochlear neurons
12/15/2009CA2334189C Bridged indenopyrrolocarbazoles
12/10/2009WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/10/2009WO2009147433A1 Heterocyclic urea derivatives for the treatment of bacterial infections
12/10/2009WO2009147431A1 Thiazolo [5, 4-b] pyridine and oxazolo [5, 4-b] pyridine derivatives as antibacterial agents
12/10/2009US20090306067 2, 4-diaminopyrimidide derivates and their use for the treatment of cancer
12/10/2009US20090306062 2,5-Disubstituted Piperidines
12/10/2009US20090304692 Triazine compounds as pi3 kinase and mtor inhibitors
12/10/2009CA2725689A1 Thiazolo [5,4-b] pyridine and oxazolo [5,4-b] pyridine derivatives as antibacterial agents
12/10/2009CA2725616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/10/2009CA2725568A1 Heterocyclic urea derivatives for the treatment of bacterial infections
12/09/2009EP2130827A1 Method for producing quinolone carboxylic acid derivative
12/09/2009EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009EP1692140B1 Compositions useful as inhibitors of protein kinases
12/09/2009EP1518517B1 Drug-delivery endovascular stent
12/09/2009EP0910633B1 Hybrid polyketide synthase I gene
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009CN100567273C Organic compounds
12/09/2009CN100567271C Improved purification of 4,4'(5')-di-t-butylcyclohexano-18-crown-6
12/08/2009US7629458 Preparation of levofloxacin and hemihydrate thereof
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/03/2009WO2009145829A1 Type iii secretion inhibitors, analogs and uses thereof
12/03/2009WO2009145456A2 Heterocyclic derivatives
12/03/2009WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009WO2009144159A1 Substituted pyridin-4-yl-methyl sulfonamidesas fungicides
12/03/2009WO2009115572A3 Novel heterocyclic compounds and uses therof
12/03/2009US20090299061 Fluorescence assays with improved sensitivity
12/03/2009US20090299060 Compounds and methods for inhibiting mitotic progression
12/03/2009US20090299058 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives, used for the treatment of cellular proliferative disorders, non-proliferative, degenerative disorders, viral infections, and/or disorders associated with viral infections
12/03/2009US20090298824 Organic compounds
12/03/2009US20090298820 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/03/2009US20090298816 Pesticides containing a bicyclic bisamide structure
12/03/2009US20090298807 Compounds
12/03/2009CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009CA2718709A1 Heterocyclic derivatives
12/02/2009EP2125831A1 Oxazinyl isoflavonoid compounds, medicaments and use
12/02/2009EP2125830A1 New process for preparing 3-methyl-4-phenylisoxazoloý3,4-d¨pyridazin-7(6h)-one
12/02/2009EP2125816A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/02/2009CN100563653C Heterocyclic compounds which are active as inhibitors of beta lactamases
12/01/2009US7625923 -4-[7-(hydroxy)-tetrahydro-pyrrolo[1,2-c]oxazol-3-ylideneamino]-2-chloro-3-methyl-benzonitrile; non-steroidal, non-toxic; side effect reduction; aging resistance; sarcopenia, osteoporosis and osteopenia, osteoporosis and osteopenia, cancer cachexia, eating disorders (e.g., anorexia) and chemotherapy
12/01/2009US7625922 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625906 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/01/2009US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/01/2009US7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
12/01/2009US7625841 invention also relates to the preparation of the compounds, to their use as herbicides and to herbicidal compositions comprising the novel compounds.
12/01/2009US7625726 Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
11/2009
11/26/2009WO2009143317A1 Triazine compounds as p13 kinase and mtor inhibitors
11/26/2009WO2009143313A1 Triazine compounds as p13 kinase and mtor inhibitors
11/26/2009WO2009117036A3 Bioactive molecules from co-cultivation of microbes
11/26/2009WO2009076440A4 Fungicidal bicyclic pyrazoles
11/26/2009US20090292118 reacting sirolimus with 2-ethoxyethyl pentafluorobenzene sulfonate under catalyzing condition using ethyl diiospropylamine or 2, 6-dimethyl pyridine as basic catalyst in the presence of an organic solvent (dichloromethane) to undergo a nucleophilic substitution reaction to obtain Biolimus A9
11/26/2009CA2721710A1 Triazine compounds as pi3 kinase and mtor inhibitors
11/26/2009CA2721692A1 Triazine compounds as p13 kinase and mtor inhibitors
11/25/2009EP2121680A1 A novel and economical process for preparing (s,s)-2, 8-diazabicycloý4.3.0¨nonane and its enantiomer
11/25/2009EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009CN101589047A Cathepsin proteases inhibitors
11/25/2009CN101585843A Process for preparing rifaximin
11/24/2009US7622584 Low driving voltages, high efficiencies, high luminance, long life-times and low power consumption; compound are anthracenes substituted with imidazo(1,2-a)pyridine ring(s); OLEDS; high electron transport capabilities
11/24/2009US7622578 Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
11/24/2009US7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
11/24/2009US7622482 anticancer agents; tyrosine kinase inhibitors based on pyrazole-3-amine linked through amine to fused heterocyclic ring such as benzimidazole, or imidazo[4,5-b]pyridine; e.g. N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-(1-(4-fluorophenyl)ethyl)-3H-imidazo[4,5-b]pyridin-5-amine
11/24/2009US7622481 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic
11/24/2009US7622477 inhibiting the neointimal growth of vasculature after catheter and balloon intervention; new isomers and 42-epimers of rapamycin alkyl ether analogs may also possess better stability in a formulation
11/24/2009CA2454015C A process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives
11/24/2009CA2433197C Gyrase inhibitors and uses thereof
11/19/2009WO2009140451A1 Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof
11/19/2009WO2009138734A2 Use of opioid compounds in peripheral pain, wound healing and scar formation
11/19/2009WO2009137916A1 Processes and intermediates for the preparation of oseltamivir and analogs thereof
11/19/2009CA2724065A1 Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof
11/18/2009EP1545453B1 Rifalazil for treating infections of clostridium difficile
11/18/2009EP0764168B1 Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
11/18/2009CN101583617A 4-(2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials
11/18/2009CN101583614A Polycyclic agents for the treatment of respiratory syncytial virus infections
11/18/2009CN101583611A Inhibitors of hepatitis C virus
11/18/2009CN101580515A Method for extracting and purifying staurosporin
11/18/2009CN101580514A Method for preparing levaquin
11/17/2009US7619246 Organic light emitting compound and organic light emitting device comprising the same
11/17/2009US7618960 Morpholine type cinnamide compound
11/17/2009CA2521950C Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
11/17/2009CA2432181C Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
11/12/2009WO2009137492A1 Heteroaryl-fused macrocyclic pyrimidine derivatives
11/12/2009WO2009137380A1 3-hydrazone piperazinyl rifamycin derivatives useful as antimicrobial agents
11/12/2009US20090281088 N-{3-[3-Fluoro-4-(4-{2-[4-(2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yloxymethyl)-phenoxy]-acetyl}-piperazin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide; for prevention and treatment of bacterial infections, caused by Mycobacterium tuberculosis
11/12/2009US20090280060 Photochromic probes
11/12/2009CA2712586A1 Antibacterial fluoroquinolone analogs
11/11/2009EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
11/11/2009EP2114158A1 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 220